UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
iShares MSCI EAFE ETF
EFA
$79.7B
| $8.98M | ﹤0.01% |
86,458
-25,514
| -23% | -$2.62M |
|
1277
Construction Partners
ROAD
$5.85B
| $8.97M | ﹤0.01% |
75,557
-528
| -0.7% | -$62.7K |
|
1278
Viking Therapeutics
VKTX
$3.93B
| $8.97M | ﹤0.01% |
229,973
-23,921
| -9% | -$773K |
|
1279
John Wiley & Sons Class A
WLY
$2.47B
| $8.93M | ﹤0.01% |
184,159
+16,217
| +10% | +$682K |
|
|
CPRX
1280
DELISTED
Catalyst Pharmaceutical
CPRX
| $8.93M | ﹤0.01% |
284,154
+3,265
| +1% | +$96.4K |
|
1281
Brookfield Asset Management
BAM
$78.1B
| $8.91M | ﹤0.01% |
198,723
| – | – |
|
1282
American States Water
AWR
$3.51B
| $8.87M | ﹤0.01% |
107,311
-5,513
| -5% | -$427K |
|
1283
iShares International Select Dividend ETF
IDV
$8.73B
| $8.86M | ﹤0.01% |
213,805
-1,033
| -0.5% | -$45.2K |
|
1284
Boot Barn
BOOT
$4.62B
| $8.85M | ﹤0.01% |
53,879
-9,732
| -15% | -$1.58M |
|
1285
Asbury Automotive
ABG
$3.82B
| $8.85M | ﹤0.01% |
44,005
-398
| -0.9% | -$78.4K |
|
1286
NMI Holdings
NMIH
$3.34B
| $8.84M | ﹤0.01% |
215,188
+19,128
| +10% | +$731K |
|
1287
Knowles
KN
$3.04B
| $8.82M | ﹤0.01% |
212,691
+14,222
| +7% | +$494K |
|
|
APGE
1288
DELISTED
Apogee Therapeutics
APGE
| $8.82M | ﹤0.01% |
66,433
+10,081
| +18% | +$908K |
|
1289
Grupo Cibest SA
CIB
$23.3B
| $8.78M | ﹤0.01% |
110,543
+110,458
| +129,951% | +$7.98M |
|
1290
Arch Capital
ACGL
$32.7B
| $8.76M | ﹤0.01% |
90,225
-3,089,527
| -97% | -$291M |
|
1291
First Financial Bankshares
FFIN
$4.75B
| $8.74M | ﹤0.01% |
252,656
+10,244
| +4% | +$331K |
|
|
CGHM
1292
Capital Group Municipal High-Income ETF
CGHM
$3.29B
| $8.73M | ﹤0.01% |
337,790
| – | – |
|
1293
BILL Holdings
BILL
$4.06B
| $8.73M | ﹤0.01% |
241,431
-95,398
| -28% | -$3.51M |
|
1294
Texas Capital Bancshares
TCBI
$4.25B
| $8.7M | ﹤0.01% |
84,272
-2,493
| -3% | -$250K |
|
1295
UFP Industries
UFPI
$4.59B
| $8.66M | ﹤0.01% |
95,451
-10,728
| -10% | -$934K |
|
1296
ArcBest
ARCB
$3.09B
| $8.63M | ﹤0.01% |
60,108
+5,371
| +10% | +$699K |
|
1297
SharkNinja
SN
$24.7B
| $8.63M | ﹤0.01% |
56,655
-66,459
| -54% | -$7.96M |
|
1298
Stride
LRN
$3.41B
| $8.62M | ﹤0.01% |
99,919
-7,575
| -7% | -$696K |
|
1299
Advance Auto Parts
AAP
$2.57B
| $8.62M | ﹤0.01% |
138,474
-21,940
| -14% | -$1.25M |
|
1300
Mirion Technologies
MIR
$4.12B
| $8.62M | ﹤0.01% |
480,488
-26,698
| -5% | -$495K |
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.